Emerging ingredients and techniques to modify gut microbial populations under the spotlight at Probiota Asia

By Gary Scattergood

- Last updated on GMT

Asia's premier probiotics summit takes place in October. ©iStock
Asia's premier probiotics summit takes place in October. ©iStock

Related tags Probiotics Probiota Asia Gut microbiota

A leading expert from Australia's Commonwealth Scientific and Industrial Research Organisation (CSIRO) will reveal the emerging opportunities to modify gut microbial populations in a keynote address at the second edition of Probiota Asia in Singapore.

This year's event​ will take place at the Hilton Singapore from October 17 to 19.

Speakers include:

  • Paul Mannion — Director of Product Innovation, Blackmores
  • Ger Rijkers — Professor of Biomedical and Life Sciences, University College Roosevelt, the Netherlands
  • Craig Silbery — CEO, Life-Space
  • Wai Mun Poon — Regulatory Affairs Consultant, Wong SJ Asia
  • Michael Conlon — Senior Research Scientist, CSIRO
  • Kourosh Kalantar-zadeh — School of Engineering, University of New South Wales, Australia
  • Ng Qin Xiang — University of Singapore

CSIRO’s Conlon will assess the as yet uncharacterised adult gut microbes that are proving to be likely new targets for probiotic and prebiotic innovations

He said: “Academics and consumers alike now recognise the important role that gut microbes play in human health.  As a result, demand for probiotic and prebiotic products is growing fast.  As the market accelerates, there are opportunities to broaden the range and effectiveness of new products that use or modulate gut microbes for health benefits.”

Key takeaways will include new evidence that dietary polyphenols can beneficially modulate gut microbes, and an assessment of  the latest technologies around faecal microbial transplantation and microencapsulation that are now proving their worth.

For the past thirty years, Michael has been conducting research on the impacts of diet on health. He has a broad knowledge of the effects of dietary polysaccharides, proteins and polyphenols. His studies have also involved the investigation of probiotics and prebiotics, as well as treatment methods such as microencapsulation and faecal microbial transplantation.

His work has been applied to understanding and helping to prevent inflammatory bowel disease, colorectal cancer and other conditions such as autism.

For information on commercial opportunities at the event, please contact Caroline Yee​.

Register as a delegate here​.

Related topics Formulation Japan China Middle East

Related news

Follow us


Food & Beverage Trailblazers

F&B Trailblazers Podcast